BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

481 related articles for article (PubMed ID: 25049269)

  • 1. Targeting potassium channels in cancer.
    Huang X; Jan LY
    J Cell Biol; 2014 Jul; 206(2):151-62. PubMed ID: 25049269
    [TBL] [Abstract][Full Text] [Related]  

  • 2. K(+) channels as therapeutic targets in oncology.
    Stühmer W; Pardo LA
    Future Med Chem; 2010 May; 2(5):745-55. PubMed ID: 21426201
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Involvement of potassium channels in the progression of cancer to a more malignant phenotype.
    Comes N; Serrano-Albarrás A; Capera J; Serrano-Novillo C; Condom E; Ramón Y Cajal S; Ferreres JC; Felipe A
    Biochim Biophys Acta; 2015 Oct; 1848(10 Pt B):2477-92. PubMed ID: 25517985
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Potassium channel blockers and openers as CNS neurologic therapeutic agents.
    Judge SI; Smith PJ; Stewart PE; Bever CT
    Recent Pat CNS Drug Discov; 2007 Nov; 2(3):200-28. PubMed ID: 18221232
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Targeting ion channels for cancer therapy by repurposing the approved drugs.
    Kale VP; Amin SG; Pandey MK
    Biochim Biophys Acta; 2015 Oct; 1848(10 Pt B):2747-55. PubMed ID: 25843679
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Research into the therapeutic roles of two-pore-domain potassium channels.
    Es-Salah-Lamoureux Z; Steele DF; Fedida D
    Trends Pharmacol Sci; 2010 Dec; 31(12):587-95. PubMed ID: 20951446
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Targeting K
    Todesca LM; Maskri S; Brömmel K; Thale I; Wünsch B; Koch O; Schwab A
    Cell Physiol Biochem; 2021 May; 55(S3):131-144. PubMed ID: 34043300
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Potassium channels and proliferation and migration of breast cancer cells.
    Zhang L; Zou W; Zhou SS; Chen DD
    Sheng Li Xue Bao; 2009 Feb; 61(1):15-20. PubMed ID: 19224049
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Pharmacology of cardiac potassium channels.
    Li GR; Dong MQ
    Adv Pharmacol; 2010; 59():93-134. PubMed ID: 20933200
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Potassium channels are a new target field in anticancer drug design.
    Villalonga N; Ferreres JC; Argilés JM; Condom E; Felipe A
    Recent Pat Anticancer Drug Discov; 2007 Nov; 2(3):212-23. PubMed ID: 18221064
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Potential Roles of Amiloride-Sensitive Sodium Channels in Cancer Development.
    Xu S; Liu C; Ma Y; Ji HL; Li X
    Biomed Res Int; 2016; 2016():2190216. PubMed ID: 27403419
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Targeting a mitochondrial potassium channel to fight cancer.
    Leanza L; Venturini E; Kadow S; Carpinteiro A; Gulbins E; Becker KA
    Cell Calcium; 2015 Jul; 58(1):131-8. PubMed ID: 25443654
    [TBL] [Abstract][Full Text] [Related]  

  • 13. SK
    Dupuy M; Gueguinou M; Potier-Cartereau M; Lézot F; Papin M; Chantôme A; Rédini F; Vandier C; Verrecchia F
    Biochem Pharmacol; 2023 Oct; 216():115774. PubMed ID: 37678626
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Tail end of the s6 segment: role in permeation in shaker potassium channels.
    Ding S; Horn R
    J Gen Physiol; 2002 Jul; 120(1):87-97. PubMed ID: 12084778
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Mechanism of block and identification of the verapamil binding domain to HERG potassium channels.
    Zhang S; Zhou Z; Gong Q; Makielski JC; January CT
    Circ Res; 1999 May; 84(9):989-98. PubMed ID: 10325236
    [TBL] [Abstract][Full Text] [Related]  

  • 16. [Physiology, pharmacology and modelling of potassium channels: focus on SK channels].
    Dilly S; Poncin S; Lamy C; Liégeois JF; Seutin V
    Med Sci (Paris); 2012 Apr; 28(4):395-402. PubMed ID: 22549867
    [TBL] [Abstract][Full Text] [Related]  

  • 17. The conduction pore of a cardiac potassium channel.
    Tai KK; Goldstein SA
    Nature; 1998 Feb; 391(6667):605-8. PubMed ID: 9468141
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Pharmacological targeting of ion channels for cancer therapy: In vivo evidences.
    Leanza L; Managò A; Zoratti M; Gulbins E; Szabo I
    Biochim Biophys Acta; 2016 Jun; 1863(6 Pt B):1385-97. PubMed ID: 26658642
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Mitochondrial potassium channels in cell death.
    Checchetto V; Azzolini M; Peruzzo R; Capitanio P; Leanza L
    Biochem Biophys Res Commun; 2018 May; 500(1):51-58. PubMed ID: 28642134
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Chloride channels in cancer: Focus on chloride intracellular channel 1 and 4 (CLIC1 AND CLIC4) proteins in tumor development and as novel therapeutic targets.
    Peretti M; Angelini M; Savalli N; Florio T; Yuspa SH; Mazzanti M
    Biochim Biophys Acta; 2015 Oct; 1848(10 Pt B):2523-31. PubMed ID: 25546839
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 25.